8-KThe WireStrategic
Agreement Terminated
Filed May 27, 2026 · 1mo ago · Accession 0001104659-26-066956
Plain English
Passage Bio, Inc. provided written notice to terminate its research, collaboration, and license agreement with Gemma Biotherapeutics, Inc. and entered into a lease termination agreement for its office space.
Filing details
- Company
- Passage BIO, Inc.
- Ticker
- PASG
- CIK
- 1787297
- Form type
- 8-K
- Filing date
- May 27, 2026
- Report date
- May 21, 2026
- Document
- pasg-20260521x8k.htm
- Size
- 145 KB